Eva Barnett
Vermögen: 6 Mio $ am 31.07.2026
Vermögen: 6 Mio $ am 31.07.2026
Eva Renee Barnett worked at Eli Lilly & Co. from 2011 to 2012 as Chief Financial Officer-Austria & Switzerland.
From 2015 to 2021, worked at AbleTo, Inc. as Chief Integration Officer.
From 2021 to 2025, worked at Immunovant, Inc. as Chief Financial & Accounting Officer.
Education includes undergraduate studies at DePauw University and an MBA from Harvard Business School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUNOVANT INC 0,08 % | 30.06.2026 | 157.761 ( 0,08 % ) | 6 Mio $ | 31.07.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUNOVANT, INC. | Finanzdirektor/CFO | 20.04.2025 |
AbleTo, Inc.
AbleTo, Inc. Medical/Nursing ServicesHealth Services Provides online therapy and coaching services for mental health conditions | Finanzdirektor/CFO | 01.03.2018 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.08.2012 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
AbleTo, Inc.
AbleTo, Inc. Medical/Nursing ServicesHealth Services Provides online therapy and coaching services for mental health conditions | Health Services |
DePauw University
DePauw University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunovant, Inc.
Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen